Immune Thrombocytopenia Induced by Immune Checkpoint Inhibitors in Solid Cancer: Case Report and Literature Review

Immune checkpoint inhibitors, including antibodies targeting programmed cell death protein-1 (PD-1) and its receptor programmed cell death ligand-1 (PD-L1), represent promising therapeutic strategies for advanced human malignancies. However, a subgroup of patients experiences various autoimmune toxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaolin, Liang, Xiuju, Liang, Jing, Li, Yan, Wang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750527/
https://www.ncbi.nlm.nih.gov/pubmed/33365266
http://dx.doi.org/10.3389/fonc.2020.530478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750527/
https://www.ncbi.nlm.nih.gov/pubmed/33365266
http://dx.doi.org/10.3389/fonc.2020.530478

Ejemplares similares